Surgery for Obstructive Sleep Apnea: Benefits and Risks
The Challenge of Obstructive Sleep Apnea
A restful night’s sleep is essential for overall well-being, but individuals with obstructive sleep apnea (OSA) often struggle to achieve it. OSA is primarily caused by structural issues in the airway, typically resulting in a narrower airway diameter. This condition leads to episodes of hypopnoea (shallow breathing) and apnoea (temporary cessation of breathing), which can significantly disrupt sleep quality and duration. Inadequate sleep can lead to immediate issues such as daytime drowsiness, impacting quality of life. Moreover, chronic sleep deprivation can pose serious long-term risks to cardiovascular health and overall life expectancy.
Exploring Surgical Alternatives
A recent study published in the JAMA Network investigates a surgical intervention as an alternative for treating moderate-to-severe obstructive sleep apnea. Traditionally, continuous positive airway pressure (CPAP) machines are the most common treatment, employing positive pressure to facilitate breathing through a facial mask. However, compliance with CPAP therapy can be inconsistent among patients.
The surgical approach aims to enlarge and stabilize the upper airway, a method that has been inconsistently utilized for OSA patients. This study’s objective was to scientifically evaluate both the benefits and complications of surgical intervention compared to standard non-surgical treatments. The surgical method involved widening and stabilizing a section of the larynx and reducing tongue volume to enhance airway diameter and improve breathing.
Study Design and Outcomes
Participants in the study were randomly assigned to either the surgical intervention group or a group receiving standard medical management. A total of 102 individuals participated, with 51 in each group. The primary outcomes measured included the apnoea-hypopnoea index (AHI) and the Epworth Sleepiness Scale (ESS) score, which assess apnea/hypopnea occurrences and daytime sleepiness, respectively.
At baseline, both groups reported similar AHI scores, with the surgical group averaging 47.9 and the medical management group averaging 45.3. An AHI score above 30 indicates severe OSA, and a clinically significant improvement is defined as a reduction of 15 points. After six months, the surgical group’s AHI improved to 20.8, with an average improvement of 27.1. In contrast, the medical management group experienced a modest average improvement of 10.8.
Daytime sleepiness also showed significant differences, with the surgical group’s ESS score improving from 12.4 at baseline to 5.3 after six months. The medical management group, however, only improved from 11.1 to 10.5 during the same period, with higher ESS scores indicating greater sleepiness.
Assessing the Risks of Surgical Intervention
The findings clearly indicate that surgical intervention provides notable benefits for treating obstructive sleep apnea. However, the study also examined the associated risks. Within the surgical group, six serious adverse events occurred, affecting three participants. One individual suffered a heart attack five days post-surgery, followed by a bleeding incident and the onset of angina. Another participant was hospitalized due to clotting issues. The remaining serious events took place prior to surgery and cannot be directly attributed to the surgical procedure.
Overall, this study suggests that surgical treatment can effectively alleviate the symptoms of obstructive sleep apnea. However, the occurrence of adverse events raises concerns. The sample size of the trial is too small to accurately assess the risks of these complications. Further research is necessary to provide a clearer understanding of surgical risks. Ultimately, the decision to pursue surgery must carefully consider the potential benefits against the risks for each individual patient.
Written by Michael McCarthy
1. MacKay S, Carney AS, Catcheside PG, Chai-Coetzer CL, Chia M, Cistulli PA, et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA. 2020.